MRI-based technologies for assessing non-alcoholic fatty liver disease

During the recent consultation on the Diagnostics Consultation Document for ‘MRI-based technologies for assessing non-alcoholic fatty liver disease’ we received a large number of comments from stakeholders. To allow sufficient time for the External Assessment Group to review the comments and undertake additional analysis, the committee meeting that was scheduled for 28 July 2022 has been postponed until 28 September 2022.